This book elaborates on current practices and policies relating to the research, development, dissemination and application of therapies aimed at improving degenerative ageing processes and extending healthy, productive longevity. It explores the intersection of longevity science, technology and society, and addresses issues such as R&D and educational policies, governance, regulation and the accessibility of emerging therapies.

It examines the practical implementation of policies for longevity therapy research, including the factors that hinder or encourage beneficial development. Key topics include the definition and evaluation of clinical benefits, regulatory frameworks and methodological issues in geroscience research. The book also considers the practical benefits of longevity studies and emerging therapies, with a focus on safety, efficacy, standardisation, and universal distribution.

Written by world-leading experts, this book makes a valuable contribution to the analysis of methodological and policy challenges, and the devising of biomedical and societal solutions to improve healthy longevity for the population.

Examines the practical implementation of policies for healthy longevity and therapy research of geroprotectors Addresses the comprehensive intersection of longevity research policy and practice Provides solutions to devise biomedical and societal solutions to improve healthy longevity for the population

Autorentext

Ilia Stambler, PhD, is the Chief Science Officer and Chairman of Vetek (Seniority) Association – the Movement for Longevity and Quality of Life, Israel, and Chairman of International Longevity Alliance (ILA). He is a fellow at the Department of Science, Technology and Society, Bar Ilan University, Israel. His research focuses on the historical and social implications of aging and longevity research, including ethical, policy, and regulatory aspects. Dr. Stambler is actively involved in advocacy for aging and longevity research and holds leadership roles in multiple organizations for healthy longevity research and advocacy. He has authored several books and over 80 academic papers. 

Inhalt

Good Practices in Healthy Longevity Medicine.- A New Medical Specialty: Clinical Guidelines and Standards for Practice and Physician Training in Healthspan Optimization.- Integrating Preventive Healthcare for Lifelong Well-being: Policy Strategies and Practical Approaches.- The Role of Longevity Medicine in Reforming Primary Healthcare.- Technological Innovations in Aging: Policy Responses and Best Practices for Healthy Longevity.- Pre-adult Healthspan Interventions (PHI): Enhancing Fulfilment and Longevity.- What is Aging and Healthy Longevity?.- The Evolving Lexicon of Longevity.- AgingasMeta-Disease: A Comprehensive Framework Integrating Set Theory with Cellular Senescence as Causal Nexus.- Wicked Issues in Healthy Longevity.- The Right to Health and Longevity An Evolving Human Right.- Enhancing Longevity Research, Development, Education and Application through Public Health and Research Policy.- Applied Bioethics in Current Longevity Medicine Policy and Practice.- A Political and Financial Blueprint for Longevity Industrialization.- Healthy Longevity: A Longer Living Society.- Longevity of Longevity Data.- Big Health Data Analyzed with AI for Longevity: How Public Institutions Could and Should Use It.- New Frontier of Longevity Through the Framework of the 'Exposome'.- Longevity Real Estate: Scaling AI for Longevity to Integrated Residential, Commercial, and Clinical Research Communities.- Analysis of Healthy Longevity in Africa: Policies, Challenges, and Opportunities.- Jewish Policies and Practices for Healthy Longevity.- Good Practices from Longevity Activism in Slovenia.- Transforming Institutions from Sickcare to Longevity.- The Road Not Taken: Lessons from British Ageing Research Policies and Initiatives.